Form 4: Medifast Director Scott Schlackman Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Scott Schlackman reports acquisition of restricted stock units and disposal of common stock related to director fees.
Summary
- On June 20, 2024, Scott Schlackman, a director of Medifast, Inc., acquired 6,596 shares of common stock through restricted stock units.
- These units were granted under the Medifast, Inc. Director's Deferred Compensation Plan as payment for annual director fees.
- Each restricted stock unit represents the right to receive one share of Medifast's common stock and will vest on June 20, 2025.
- Schlackman also disposed of 14,380.707 shares of common stock.
- Following these transactions, Schlackman beneficially owns 14,380.707 shares of Medifast common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects standard compensation practices and regulatory filings.
Industry Context
This filing is a routine disclosure related to director compensation and stock ownership, common for publicly traded companies.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders as it relates to director compensation.
Key Dates
| Date | Description |
|---|---|
| 06/20/2024 | Date of transaction: Acquisition of restricted stock units and disposal of common stock. |
| 06/20/2025 | Vesting date for the restricted stock units. |
| 06/24/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.